Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

Abstract Background Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcom...

Full description

Bibliographic Details
Main Authors: Kamila Romanowski, Leslie Y. Chiang, David Z. Roth, Mel Krajden, Patrick Tang, Victoria J. Cook, James C. Johnston
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Infectious Diseases
Subjects:
Mycobacterium tuberculosis
INH resistance
Tuberculosis treatment
Online Access:http://link.springer.com/article/10.1186/s12879-017-2706-0

Internet

http://link.springer.com/article/10.1186/s12879-017-2706-0

Similar Items